KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1

Historical Holders from Q3 2024 to Q2 2025

CUSIP
48576UAD8
Type / Class
Debt / NOTE 6.000% 5/1
All holders as of June 30, 2025
Q2 2025
Total 13F principal, excl. options
102M
Holdings value
$79.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
4
Number of buys
4
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1

Period Principal Value Change Price Investors
2025 Q2 $102M $79.5M +$79.5M $0.74 4
2024 Q4 $0 $0 -$5.94M 0
2024 Q3 $8.87K $5.94M +$5.94M $670.00 1